buyWeak
David W Gryska bought $18k of DFTX
director at Mind Medicine (MindMed) Inc.. 2,500 shares at an average of $7.17, traded Dec 5, 2024, filed Dec 5, 2024.
Conviction score
18Value
$18k
2,500 shares
Holdings after
19,851
+14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$18k at market
- +3Relative to holdingsHoldings up 14%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-133724, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2024 | POpen-market purchase Common Shares | +2,500 | $7.17 | $18k | 19,851 | Dec 5, 2024 |
Related signals
Other insiders at Mind Medicine (MindMed) Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Mind Medicine (MindMed) Inc. | Robert Barrow Chief Executive Officer | $1.2M 31,550 shares | -1% | |
| 27Weak | Mind Medicine (MindMed) Inc. | Brandi Roberts Chief Financial Officer | $123k 3,377 shares | -1% | |
| 28Weak | Mind Medicine (MindMed) Inc. | Mark Sullivan Chief Legal Officer | $514k 14,051 shares | -3% | |
| 20Weak | Mind Medicine (MindMed) Inc. | Matthew T. Wiley Chief Commercial Officer | $113k 3,097 shares | -1% | |
| 26Weak | Mind Medicine (MindMed) Inc. | Dan Karlin Chief Medical Officer | $397k 10,853 shares | -1% | |
| 26Weak | Mind Medicine (MindMed) Inc. | Robert Barrow Chief Executive Officer | $722k 19,023 shares | -1% | |
| 45Moderate | Mind Medicine (MindMed) Inc. | Robert Barrow Chief Executive Officer | $1.3M 29,208 shares | -3% | |
| 21Weak | Mind Medicine (MindMed) Inc. | Matthew T. Wiley Chief Commercial Officer | $129k 2,867 shares | -2% | |
| 28Weak | Mind Medicine (MindMed) Inc. | Brandi Roberts Chief Financial Officer | $136k 3,013 shares | -1% | |
| 27Weak | Mind Medicine (MindMed) Inc. | Dan Karlin Chief Medical Officer | $452k 10,035 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.